Psmb8 inhibits mitochondrial fission and alleviates myocardial ischaemia/reperfusion injury by targeting Drp1 degradation

The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the immunoproteasome catalytic subunits, is a key regulator of protein homoeostasis, inflammation and some cardiac diseases. Here, we found that the expression...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 15; no. 11; pp. 803 - 16
Main Authors Su, Hui-Xiang, Xu, Luo-Luo, Li, Pang-Bo, Bi, Hai-Lian, Jiang, Wen-Xi, Li, Hui-Hua
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.11.2024
Springer Nature B.V
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the immunoproteasome catalytic subunits, is a key regulator of protein homoeostasis, inflammation and some cardiac diseases. Here, we found that the expression level and activity of Psmb8 were significantly reduced in the heart of I/R mice and in subjects with myocardial infarction (MI). Cardiomyocyte-specific Psmb8 overexpression in mice markedly ameliorated I/R-mediated cardiac injury and dysfunction, which was accompanied by reduced mitochondrial division via the downregulation of dynamin-related protein-1 (Drp1). However, Psmb8 knockout (KO) mice exhibited the opposite changes. The effects of Psmb8 on mitochondrial fission and apoptosis was confirmed in primary cardiomyocytes with overexpression or knockdown of Psmb8 in vitro. Mechanistically, Psmb8 was directly associated with Drp1 and enhanced its degradation, which subsequently suppressed I/R-mediated mitochondrial fission and cardiac injury. Conversely, knockdown of Drp1 in Psmb8-KO mice restored I/R-induced cardiac dysfunction and mitochondrial dynamic imbalance. Our study identified a new cardioprotective role of Psmb8 in cardiac I/R damage through targeting Drp1, and highlight that increasing Psmb8 activity may constitute a promising therapy for ischaemic heart disease.
AbstractList The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the immunoproteasome catalytic subunits, is a key regulator of protein homoeostasis, inflammation and some cardiac diseases. Here, we found that the expression level and activity of Psmb8 were significantly reduced in the heart of I/R mice and in subjects with myocardial infarction (MI). Cardiomyocyte-specific Psmb8 overexpression in mice markedly ameliorated I/R-mediated cardiac injury and dysfunction, which was accompanied by reduced mitochondrial division via the downregulation of dynamin-related protein-1 (Drp1). However, Psmb8 knockout (KO) mice exhibited the opposite changes. The effects of Psmb8 on mitochondrial fission and apoptosis was confirmed in primary cardiomyocytes with overexpression or knockdown of Psmb8 in vitro. Mechanistically, Psmb8 was directly associated with Drp1 and enhanced its degradation, which subsequently suppressed I/R-mediated mitochondrial fission and cardiac injury. Conversely, knockdown of Drp1 in Psmb8-KO mice restored I/R-induced cardiac dysfunction and mitochondrial dynamic imbalance. Our study identified a new cardioprotective role of Psmb8 in cardiac I/R damage through targeting Drp1, and highlight that increasing Psmb8 activity may constitute a promising therapy for ischaemic heart disease.
Abstract The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the immunoproteasome catalytic subunits, is a key regulator of protein homoeostasis, inflammation and some cardiac diseases. Here, we found that the expression level and activity of Psmb8 were significantly reduced in the heart of I/R mice and in subjects with myocardial infarction (MI). Cardiomyocyte-specific Psmb8 overexpression in mice markedly ameliorated I/R-mediated cardiac injury and dysfunction, which was accompanied by reduced mitochondrial division via the downregulation of dynamin-related protein-1 (Drp1). However, Psmb8 knockout (KO) mice exhibited the opposite changes. The effects of Psmb8 on mitochondrial fission and apoptosis was confirmed in primary cardiomyocytes with overexpression or knockdown of Psmb8 in vitro. Mechanistically, Psmb8 was directly associated with Drp1 and enhanced its degradation, which subsequently suppressed I/R-mediated mitochondrial fission and cardiac injury. Conversely, knockdown of Drp1 in Psmb8-KO mice restored I/R-induced cardiac dysfunction and mitochondrial dynamic imbalance. Our study identified a new cardioprotective role of Psmb8 in cardiac I/R damage through targeting Drp1, and highlight that increasing Psmb8 activity may constitute a promising therapy for ischaemic heart disease.
The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the immunoproteasome catalytic subunits, is a key regulator of protein homoeostasis, inflammation and some cardiac diseases. Here, we found that the expression level and activity of Psmb8 were significantly reduced in the heart of I/R mice and in subjects with myocardial infarction (MI). Cardiomyocyte-specific Psmb8 overexpression in mice markedly ameliorated I/R-mediated cardiac injury and dysfunction, which was accompanied by reduced mitochondrial division via the downregulation of dynamin-related protein-1 (Drp1). However, Psmb8 knockout (KO) mice exhibited the opposite changes. The effects of Psmb8 on mitochondrial fission and apoptosis was confirmed in primary cardiomyocytes with overexpression or knockdown of Psmb8 in vitro. Mechanistically, Psmb8 was directly associated with Drp1 and enhanced its degradation, which subsequently suppressed I/R-mediated mitochondrial fission and cardiac injury. Conversely, knockdown of Drp1 in Psmb8-KO mice restored I/R-induced cardiac dysfunction and mitochondrial dynamic imbalance. Our study identified a new cardioprotective role of Psmb8 in cardiac I/R damage through targeting Drp1, and highlight that increasing Psmb8 activity may constitute a promising therapy for ischaemic heart disease.The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the immunoproteasome catalytic subunits, is a key regulator of protein homoeostasis, inflammation and some cardiac diseases. Here, we found that the expression level and activity of Psmb8 were significantly reduced in the heart of I/R mice and in subjects with myocardial infarction (MI). Cardiomyocyte-specific Psmb8 overexpression in mice markedly ameliorated I/R-mediated cardiac injury and dysfunction, which was accompanied by reduced mitochondrial division via the downregulation of dynamin-related protein-1 (Drp1). However, Psmb8 knockout (KO) mice exhibited the opposite changes. The effects of Psmb8 on mitochondrial fission and apoptosis was confirmed in primary cardiomyocytes with overexpression or knockdown of Psmb8 in vitro. Mechanistically, Psmb8 was directly associated with Drp1 and enhanced its degradation, which subsequently suppressed I/R-mediated mitochondrial fission and cardiac injury. Conversely, knockdown of Drp1 in Psmb8-KO mice restored I/R-induced cardiac dysfunction and mitochondrial dynamic imbalance. Our study identified a new cardioprotective role of Psmb8 in cardiac I/R damage through targeting Drp1, and highlight that increasing Psmb8 activity may constitute a promising therapy for ischaemic heart disease.
ArticleNumber 803
Author Su, Hui-Xiang
Li, Hui-Hua
Bi, Hai-Lian
Jiang, Wen-Xi
Li, Pang-Bo
Xu, Luo-Luo
Author_xml – sequence: 1
  givenname: Hui-Xiang
  surname: Su
  fullname: Su, Hui-Xiang
  organization: Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University
– sequence: 2
  givenname: Luo-Luo
  surname: Xu
  fullname: Xu, Luo-Luo
  organization: Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University
– sequence: 3
  givenname: Pang-Bo
  surname: Li
  fullname: Li, Pang-Bo
  organization: Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University
– sequence: 4
  givenname: Hai-Lian
  surname: Bi
  fullname: Bi, Hai-Lian
  organization: Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District
– sequence: 5
  givenname: Wen-Xi
  orcidid: 0000-0001-9638-291X
  surname: Jiang
  fullname: Jiang, Wen-Xi
  email: wenxi_jiang@163.com
  organization: Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University
– sequence: 6
  givenname: Hui-Hua
  orcidid: 0000-0001-5983-4016
  surname: Li
  fullname: Li, Hui-Hua
  email: hhli1935@aliyun.com
  organization: Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39516219$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNUREvpH2CBIrFhE-pXEnuFUHlVqgQLWFs39k3Go8Qe7KTS_Pt6JqW0LPDG1vV3jq-uz8vixAePRfGakveUcHmZBBVUVYSJirRUqoo-K84YEbQSUqqTR-fT4iKlLcmLc8Lq5kVxylVNG0bVWbH_kaZOls5vXOfmVE5uDmYTvI0OxrJ3KbngS_C2hHHEWwczZmgfDER7IFwyG8DJwWXEHcZ-OfLOb5e4L7t9OUMccHZ-KD_FHS0tDhEszBl6VTzvYUx4cb-fF7--fP559a26-f71-urjTWWEYnOlGtohMmnANKAaoEiRENkabjvSilb2rIFGEklsrtW9lKIVlvZKAqlrRvh5cb362gBbvYtugrjXAZw-FkIcNMTZmRG1EaxXoreoeCcYGJW9URHRtLI2tTHZ68PqtVu6Ca1BP0cYn5g-vfFuo4dwqymthRJCZYd39w4x_F4wzXrKI8RxBI9hSZpTJlvBOD2gb_9Bt2GJPs_qQDVMiJqLTL153NJDL3--OANsBUwMKUXsHxBK9CFKeo2SzlHSxyhpmkV8FaUM-wHj37f_o7oDEYfM-w
Cites_doi 10.1172/JCI45709
10.1038/s41401-020-00518-y
10.3390/cells9010214
10.1007/s00018-023-04867-9
10.1038/nm.2282
10.1016/S1534-5807(01)00055-7
10.1042/CS20160030
10.1371/journal.pone.0078564
10.1161/CIRCULATIONAHA.106.637827
10.1126/sciadv.aau0495
10.1038/sj.embor.7401062
10.1016/j.ejphar.2023.176235
10.1016/j.ejphar.2023.176011
10.1016/j.lfs.2020.118628
10.1074/jbc.M806487200
10.1038/s41586-022-05060-x
10.1161/HYPERTENSIONAHA.117.10390
10.1038/s41421-023-00622-3
10.1016/j.ymthe.2019.09.025
10.4049/jimmunol.1800197
10.1016/j.redox.2023.102706
10.1074/jbc.M110.144238
10.1038/s41392-022-00933-z
10.1074/jbc.270.46.27687
10.2741/4027
10.1096/fj.08-105940
10.1038/s41392-023-01547-9
10.1161/HYPERTENSIONAHA.118.11813
10.1242/jcs.257808
10.1083/jcb.200611064
10.1073/pnas.0808249105
10.1152/ajpheart.00028.2018
10.3390/nu15041049
10.1161/CIRCRESAHA.112.270983
10.1038/sj.emboj.7601249
10.3390/cells10113216
10.1097/HJH.0000000000003075
10.1038/sj.cdd.4401544
10.1016/j.bbrc.2017.05.011
ContentType Journal Article
Copyright The Author(s) 2024 corrected publication 2025
2024. The Author(s).
Copyright Springer Nature B.V. Nov 2024
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024 corrected publication 2025
– notice: 2024. The Author(s).
– notice: Copyright Springer Nature B.V. Nov 2024
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41419-024-07189-1
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-4889
EndPage 16
ExternalDocumentID oai_doaj_org_article_c42f94fde93b42ac9f26e9046785c5cc
PMC11549449
39516219
10_1038_s41419_024_07189_1
Genre Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China 82030009
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
E3Z
EBLON
EBS
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c492t-961bee28cac6a96a1e1e0087c3db07478f26a68080d7c35f88474d1f98a055203
IEDL.DBID DOA
ISSN 2041-4889
IngestDate Wed Aug 27 01:22:33 EDT 2025
Thu Aug 21 18:30:33 EDT 2025
Tue Aug 05 11:01:25 EDT 2025
Wed Aug 13 08:21:51 EDT 2025
Thu Apr 03 07:04:58 EDT 2025
Tue Jul 01 03:50:18 EDT 2025
Fri Feb 21 02:47:31 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c492t-961bee28cac6a96a1e1e0087c3db07478f26a68080d7c35f88474d1f98a055203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5983-4016
0000-0001-9638-291X
OpenAccessLink https://doaj.org/article/c42f94fde93b42ac9f26e9046785c5cc
PMID 39516219
PQID 3126244534
PQPubID 2041963
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_c42f94fde93b42ac9f26e9046785c5cc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11549449
proquest_miscellaneous_3128742319
proquest_journals_3126244534
pubmed_primary_39516219
crossref_primary_10_1038_s41419_024_07189_1
springer_journals_10_1038_s41419_024_07189_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-08
PublicationDateYYYYMMDD 2024-11-08
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-08
  day: 08
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2024
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References W Chen (7189_CR26) 2023; 8
Q Gao (7189_CR27) 2022; 7
S Frank (7189_CR40) 2001; 1
J Li (7189_CR10) 2019; 73
A Angeles (7189_CR5) 2012; 17
FD Li (7189_CR11) 2019; 202
JX Wang (7189_CR30) 2011; 17
J Gao (7189_CR31) 2023; 957
7189_CR3
P Xie (7189_CR39) 2009; 284
M Karbowski (7189_CR21) 2007; 178
F Teng (7189_CR36) 2022; 40
7189_CR6
H Wang (7189_CR24) 2011; 286
S Li (7189_CR32) 2013; 8
GM Cereghetti (7189_CR29) 2008; 105
7189_CR23
R Yonashiro (7189_CR22) 2006; 25
J Li (7189_CR15) 2011; 121
J Li (7189_CR9) 2018; 71
Y Yang (7189_CR38) 1995; 270
HX Su (7189_CR16) 2023; 80
C Depre (7189_CR33) 2006; 114
TM Scarabelli (7189_CR2) 2004; 11
X Xie (7189_CR7) 2019; 5
ZP Cai (7189_CR14) 2008; 22
YL Zhang (7189_CR35) 2022; 2022
S Liu (7189_CR37) 2024; 10
JY Jin (7189_CR25) 2021; 42
Y Wu (7189_CR1) 2021; 264
KN Shi (7189_CR18) 2023; 62
W Yan (7189_CR8) 2017; 490
K Atkins (7189_CR20) 2016; 130
7189_CR17
S Wang (7189_CR12) 2020; 28
G Paradies (7189_CR4) 2018; 315
JQ Bai (7189_CR34) 2024; 963
Z Tian (7189_CR13) 2012; 111
JT Cribbs (7189_CR28) 2007; 8
C Kuppe (7189_CR19) 2022; 608
39952946 - Cell Death Dis. 2025 Feb 14;16(1):98. doi: 10.1038/s41419-025-07408-3.
References_xml – volume: 121
  start-page: 3689
  year: 2011
  ident: 7189_CR15
  publication-title: J Clin Investig
  doi: 10.1172/JCI45709
– volume: 42
  start-page: 655
  year: 2021
  ident: 7189_CR25
  publication-title: Acta Pharm Sin
  doi: 10.1038/s41401-020-00518-y
– ident: 7189_CR3
  doi: 10.3390/cells9010214
– volume: 80
  start-page: 231
  year: 2023
  ident: 7189_CR16
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-023-04867-9
– volume: 17
  start-page: 71
  year: 2011
  ident: 7189_CR30
  publication-title: Nat Med
  doi: 10.1038/nm.2282
– volume: 1
  start-page: 515
  year: 2001
  ident: 7189_CR40
  publication-title: Dev Cell
  doi: 10.1016/S1534-5807(01)00055-7
– volume: 130
  start-page: 1861
  year: 2016
  ident: 7189_CR20
  publication-title: Clin Sci
  doi: 10.1042/CS20160030
– volume: 8
  start-page: e78564
  year: 2013
  ident: 7189_CR32
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0078564
– volume: 114
  start-page: 1821
  year: 2006
  ident: 7189_CR33
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.637827
– volume: 5
  year: 2019
  ident: 7189_CR7
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aau0495
– volume: 8
  start-page: 939
  year: 2007
  ident: 7189_CR28
  publication-title: EMBO Rep
  doi: 10.1038/sj.embor.7401062
– volume: 963
  year: 2024
  ident: 7189_CR34
  publication-title: Eur J Pharm
  doi: 10.1016/j.ejphar.2023.176235
– volume: 957
  year: 2023
  ident: 7189_CR31
  publication-title: Eur J Pharm
  doi: 10.1016/j.ejphar.2023.176011
– volume: 264
  year: 2021
  ident: 7189_CR1
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.118628
– volume: 284
  start-page: 5488
  year: 2009
  ident: 7189_CR39
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M806487200
– volume: 608
  start-page: 766
  year: 2022
  ident: 7189_CR19
  publication-title: Nature
  doi: 10.1038/s41586-022-05060-x
– volume: 71
  start-page: 866
  year: 2018
  ident: 7189_CR9
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.117.10390
– volume: 10
  start-page: 24
  year: 2024
  ident: 7189_CR37
  publication-title: Cell Discov
  doi: 10.1038/s41421-023-00622-3
– volume: 28
  start-page: 279
  year: 2020
  ident: 7189_CR12
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2019.09.025
– volume: 202
  start-page: 1176
  year: 2019
  ident: 7189_CR11
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1800197
– volume: 62
  year: 2023
  ident: 7189_CR18
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2023.102706
– volume: 286
  start-page: 11649
  year: 2011
  ident: 7189_CR24
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.144238
– volume: 7
  start-page: 103
  year: 2022
  ident: 7189_CR27
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-022-00933-z
– volume: 270
  start-page: 27687
  year: 1995
  ident: 7189_CR38
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.46.27687
– volume: 17
  start-page: 1904
  year: 2012
  ident: 7189_CR5
  publication-title: Front Biosci
  doi: 10.2741/4027
– volume: 22
  start-page: 4248
  year: 2008
  ident: 7189_CR14
  publication-title: FASEB J
  doi: 10.1096/fj.08-105940
– volume: 8
  start-page: 333
  year: 2023
  ident: 7189_CR26
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-023-01547-9
– volume: 73
  start-page: 92
  year: 2019
  ident: 7189_CR10
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.118.11813
– volume: 2022
  year: 2022
  ident: 7189_CR35
  publication-title: Oxid Med Cell Longev
– ident: 7189_CR23
  doi: 10.1242/jcs.257808
– volume: 178
  start-page: 71
  year: 2007
  ident: 7189_CR21
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200611064
– volume: 105
  start-page: 15803
  year: 2008
  ident: 7189_CR29
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0808249105
– volume: 315
  start-page: H1341
  year: 2018
  ident: 7189_CR4
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00028.2018
– ident: 7189_CR17
  doi: 10.3390/nu15041049
– volume: 111
  start-page: 532
  year: 2012
  ident: 7189_CR13
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.112.270983
– volume: 25
  start-page: 3618
  year: 2006
  ident: 7189_CR22
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601249
– ident: 7189_CR6
  doi: 10.3390/cells10113216
– volume: 40
  start-page: 765
  year: 2022
  ident: 7189_CR36
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000003075
– volume: 11
  start-page: S144
  year: 2004
  ident: 7189_CR2
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4401544
– volume: 490
  start-page: 84
  year: 2017
  ident: 7189_CR8
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.05.011
– reference: 39952946 - Cell Death Dis. 2025 Feb 14;16(1):98. doi: 10.1038/s41419-025-07408-3.
SSID ssj0000330256
Score 2.399342
Snippet The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the...
Abstract The mitochondrial dynamic imbalance is an important cause of myocardial ischaemia/reperfusion (I/R) injury and dysfunction. Psmb8, as one of the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 803
SubjectTerms 14/19
14/28
38/1
38/77
631/80/304
64/60
692/699/75/2/1674
82/58
82/80
96/109
Animals
Antibodies
Apoptosis
Biochemistry
Biomedical and Life Sciences
Cardiomyocytes
Catalytic subunits
Cell Biology
Cell Culture
Coronary artery disease
Dynamin
Dynamins - genetics
Dynamins - metabolism
Heart diseases
Humans
Immunology
Ischemia
Life Sciences
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Mitochondria
Mitochondrial Dynamics
Myocardial infarction
Myocardial Infarction - genetics
Myocardial Infarction - metabolism
Myocardial Infarction - pathology
Myocardial Reperfusion Injury - genetics
Myocardial Reperfusion Injury - metabolism
Myocardial Reperfusion Injury - pathology
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
Proteasome Endopeptidase Complex - metabolism
Proteolysis
Reperfusion
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgERIXxJvCgozEDaKNHce1T4jXaoUE4sBKvVl-skHULU2L1H_PjJN2VV6XHGxHmXhmPGPP-BtCnvOYpBUuVqx1vBLJpso5JuEhYuOFb-uCpffxkzw7Fx9m7Ww8cOvHtMrdmlgW6rDweEZ-0jAuwRS1jXi1_FFh1SiMro4lNK6Sawhdhild09l0f8ZSw2YdTPp4V6Zu1EkvmMBbO1zgzR2lK3Zgjwps_998zT9TJn-LmxZzdHqL3Bz9SPp6YPxtciXmO-T6UFlye5dsP_dzp2iXLzrXrXs6B8WFhS4HlDeaOsx9zdTmQLGWys8OPU4634JhQ4H5Trses-nnHeJHLeMqbcr4Ln8DFlC3pUMCOVBG362WjAaEnBiqM90j56fvv7w9q8YqC5UXmq8rLZmLkStvvbRaWhZZRKA63wRX0PUTlxYLdNQB2tqkwJ6JwJJWtm5bXjf3yVFe5PiQUN04m6x2qY5cpDhVVsdaBW4RJS9wOSEvdnNtlgOYhilB8EaZgTMGOGMKZwybkDfIjv1IBMIuDYvVVzPqlfGCJy1SiPBtwa3XQG3UsOmfqta33k_I8Y6ZZtTO3lzK0oQ823eDXmGwxOa42JQxCqPYTE_Ig4H3e0oacEslxx51IBUHpB725O6iYHcj-pEWAl59uROgS7r-PReP_v8bj8kNjjJdjruPydF6tYlPwFlau6dFI34BK_EVAw
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZWi5C4IN4EFmQkbhCIHcdrHxDitVohLeJApb1ZtmOzQdu0NC0i_54ZJykqlBuXHGxHmcwjM45nviHkKQ9RWuFCzirHcxFtzJ1jEi4ilF74qkhYemef5OlMfDyvzg_I1O5oZGC3d2uH_aRmq8sXP7_3r8HgXw0l4-plJ5jAUhwusBxH6Rx2Q1fAMx2joZ6N4X76MsPmHVz8WDuz_9Yd_5Rg_PfFnn-nUP5xjprc08kNcn2MK-mbQRFukoPQ3iJXh06T_W3Sf-7mTtGmvWhcs-7oHAwZ3r2tUf9obDAXtqW2rSn2VvnRYARK5z04OlSgS9p0mF0_bxBPahlWcZPWN-03EAl1PR0SyoEy-n61ZLRGCIqhW9MdMjv58OXdaT52Xci90Hyda8lcCFx566XV0rLAAgLX-bJ2CW0_cmmxYUdRw1gVFfg3UbOolS2qihflXXLYLtpwn1BdOhutdrEIXMRwrKwOhaq5RdS8msuMPJt4bZYDuIZJh-KlMoNkDEjGJMkYlpG3KI7tSgTGTgOL1Vcz2pnxgkctYh3g2YJbr4HaoAtwB6rylfcZOZqEaSZlMyXjEsKcqhQZebKdBjvDwxPbhsUmrVF4qs10Ru4Nst9SUkKYKjnOqB2t2CF1d6ZtLhKWN6IhaSHg1ueTAv2m69-8ePA_ePGQXOOo-ekn-RE5XK824RGEWGv3ONnNL2psJYw
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqIiQuqLwDLTISN4iIHce1j7BQVUggDlTqzbIdmwax3tVmt9L-e2acZKuFcuCSgx_KyDPjGdsz3xDymocorXChZI3jpYg2ls4xCR8Rai98U2UsvS9f5fmF-HzZXB4QPuXC5KD9DGmZt-kpOuxdL5jAdBsuMOVG6RJOPHcQuh2leiZnu3uVCg7oYMbH_JiqVrdM3bNBGar_Nv_y7zDJP95Kswk6OyL3R9-Rvh-ofUAOQnpI7g7VJLePyPZbP3eKdumqc926p3NQVtjcUosyRmOH8a6J2tRSrJ9y3aGXSedbMGYoJL9o12ME_bxDzKhlWMVNHt-ln7Ds1G3pEDQOlNGPqyWjLcJMDBWZHpOLs0_fZ-flWFmh9ELzdaklcyFw5a2XVkvLAgsITufr1mVE_cilxaIcVQttTVRgw0TLola2ahpe1U_IYVqk8IxQXTsbrXaxClzEcKqsDpVquUVkvJbLgryZ1tosBwANkx--a2UGzhjgjMmcMawgH5Adu5EIfp0bFqsfZhQG4wWPWsQ2wL8Ft14DtUHDQf9UNb7xviDHEzPNqJG9qRmX4Mo0tSjIq1036BI-kNgUFps8RuHLNdMFeTrwfkdJDa6o5Nij9qRij9T9ntRdZbxuRDzSQsDUt5MA3dD177V4_n_DX5B7HGU8X3kfk8P1ahNOwGFau5dZQ34D0acS2Q
  priority: 102
  providerName: Springer Nature
Title Psmb8 inhibits mitochondrial fission and alleviates myocardial ischaemia/reperfusion injury by targeting Drp1 degradation
URI https://link.springer.com/article/10.1038/s41419-024-07189-1
https://www.ncbi.nlm.nih.gov/pubmed/39516219
https://www.proquest.com/docview/3126244534
https://www.proquest.com/docview/3128742319
https://pubmed.ncbi.nlm.nih.gov/PMC11549449
https://doaj.org/article/c42f94fde93b42ac9f26e9046785c5cc
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdbx2AvY9_z1gUN9raZWrKsSI9pllICLWVbIW9GkiXqsrghTgZ52d--O9nJmn2wl70oIClw3Ifu5Dv9jpB33AdphPUpKyxPRTAhtZZJGITPnXBFFrH0zs7l6aWYzorZrVZfWBPWwQN3jDtyggctQuV1bgU3TgcuvYZb3VAVrnAOT1_webcuU_EMhms6OPP-lUyWq6NWMIHvdbjANztKp2zPE0XA_j9Fmb8XS_6SMY2O6OQRedhHkHTUUf6Y3PHNE3K_6ym5eUo2F-3cKlo3V7WtVy2dg8nCEddUqGk01Fj12lDTVBS7qHyrMdak8w24NFSVr7RusY5-XiNy1MIvwzrur5trYD61G9qVjgNl9ONywWiFYBNdX6Zn5PJk8mV8mvb9FVInNF-lWjLrPVfOOGm0NMwzjxB1Lq9sxNUHVhtszZFVMFcEBZ5MVCxoZbKi4Fn-nBw0N41_SSgIxwSjbcg8F8EPldE-UxU3iI9XcZmQ91tel4sORqOM6e9clZ1kSpBMGSVTsoQcozh2OxECO06AYpS9YpT_UoyEHG6FWfZ22ZY54xICmiIXCXm7WwaLwjSJafzNOu5RmL9mOiEvOtnvKMkhIJUcV9SeVuyRur_S1FcRtRtxj7QQ8NcPWwX6SdffefHqf_DiNXnAUfPj5_BDcrBarv0bCKZWdkDuDmfDAbk3Gk0_T-H3eHJ-8Qlmx3I8iDYF45lQOH6f_AC2tiUh
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ8ReEN8UBhgJniBa_JFgPyDE2KaObdWENmlvxnZslommpWlB_af4G_E5Safy9baXPsRue8nvfHfxnX-H0AvqfK65cQnJDE241z4xhuThgztmuc3SyKV3NMwHp_zjWXa2hn52Z2GgrLKzidFQF2MLe-RbjNA8uKKM8XeTbwl0jYLsatdCo1GLA7f4EV7Z6rf7OwHfl5Tu7Z58GCRtV4HEcklnicyJcY4Kq22uZa6JIw6I2SwrTGST9zTX0JAiLcK1zItgv3lBvBQ6zTKasvC719A6Z-FVpofWt3eHx5-WuzopYxBEtKdzUia2ak44nBOiHM4KCZmQFQ8YGwX8Lbr9s0jzt0xtdIB7t9DNNnLF7xtVu43WXHUHXW96WS7uosVxPTICl9V5acpZjUfBVATTWhWg4diXUG1bYV0VGLq3fC8hxsWjRXCloKJfcVlD_f6oBMaqiZv6eZxfVhcBdGwWuClZD5LhnemE4AJILpp-UPfQ6ZUgcB_1qnHlHiIsmdFeS-NTR7l3b4SWLhUF1cDLV9C8j151z1pNGvoOFdPuTKgGGRWQUREZRfpoG-BYzgTq7XhhPP2i2pWsLKdecl-48N-caiuDtE6mweGIzGbW9tFmB6Zq7UGtLrW3j54vh8NKhvSMrtx4HucIyJsT2UcPGuyXkrAQCOcURsSKVqyIujpSleeRLRz4liTn4auvOwW6lOvfz-LR_2_jGboxODk6VIf7w4PHaIOCfsfN9k3Um03n7kkI1Wbmabs-MPp81UvyFxaOUgA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRSAuiDeFBYwEJ4gaP5LaB4SAUu2ysNoDK_VmbMdmg2hamhaUv8avw-MkXZXXbS852G4z9TzrGX-D0BPqfK65cQnJDE241z4xhuThwR2z3GZpxNL7cJTvn_B302y6g372d2GgrLK3idFQF3MLZ-RDRmgeXFHG-NB3ZRHH48nLxbcEOkhBprVvp9GKyKFrfoS_b_WLg3Hg9VNKJ28_vtlPug4DieWSrhKZE-McFVbbXMtcE0ccgLRZVpiILO9prqE5RVqEscyLYMt5QbwUOs0ymrLwvRfQxRHLCOjYaDranO-kjEE40d3TSZkY1pxwuDFEOdwaEjIhW74wtgz4W5z7Z7nmbznb6Aon19DVLobFr1qhu452XHUDXWq7WjY3UXNcz4zAZXVamnJV41kwGsHIVgXIOvYl1N1WWFcFhj4u30uIdvGsCU4VhPUrLmuo5J-VgF21cEu_juvL6ktgPzYNbovXA2V4vFwQXADcRdsZ6hY6OZf9v412q3nl7iIsmdFeS-NTR7l3I6GlS0VBNSD0FTQfoGf9XqtFC-ShYgKeCdVyRgXOqMgZRQboNbBjsxJAuOPAfPlZdTqtLKdecl-48G5OtZWBWifT4HpEZjNrB2ivZ6bqLEOtzuR4gB5vpoNOQ6JGV26-jmsEZNCJHKA7Le83lLAQEucUZsSWVGyRuj1TlacRNxyQlyTn4aPPewE6o-vfe3Hv_z_jEbocFFG9Pzg6vI-uUBDveOq-h3ZXy7V7EGK2lXkYlQOjT-etjb8AC4VU0A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psmb8+inhibits+mitochondrial+fission+and+alleviates+myocardial+ischaemia%2Freperfusion+injury+by+targeting+Drp1+degradation&rft.jtitle=Cell+death+%26+disease&rft.au=Hui-Xiang+Su&rft.au=Luo-Luo+Xu&rft.au=Pang-Bo+Li&rft.au=Hai-Lian+Bi&rft.date=2024-11-08&rft.pub=Nature+Publishing+Group&rft.eissn=2041-4889&rft.volume=15&rft.issue=11&rft.spage=1&rft.epage=16&rft_id=info:doi/10.1038%2Fs41419-024-07189-1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c42f94fde93b42ac9f26e9046785c5cc
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon